AMN Healthcare (AMN) Q2 2026 Earnings Call Transcript
AMN Healthcare reported Q2 2026 revenue of $673 million, up 2% year over year and 6% above the top end of guidance, with adjusted EPS of $0.77. Adjusted EBITDA was $73 million (10.9% margin) after $27 million in nonrecurring billing true-ups. Q3 revenue guidance is $640 million to $655 million. AMN also authorized share repurchases and acquired Jaide Health and ESSENTIAL.
How this was made
The 30-second read
Why it matters
Traders can update models using the provided Q2 results and explicit Q3 revenue and margin ranges, then stress-test segment drivers: travel nurse and allied volume growth versus locum tenens decline and language services pricing headwinds.
Market read
The article is a primary disclosure of earnings and guidance with segment-level drivers that can directly affect near-term valuation and positioning in healthcare staffing.
What to watch
Visa appointment backlog timing could delay international nurse ramp into 2027, and the locum tenens business is still showing below-seasonal growth and an ongoing technology transformation that may pressure near-term results.
Background
AMN Healthcare’s Q2 2026 earnings call covers revenue, adjusted profitability, segment performance, and Q3 guidance, including labor disruption normalization and technology-enabled service expansion.
Ticker impact
AMN reported Q2 revenue of $673M, adjusted EPS of $0.77, and guided Q3 revenue to $640M-$655M with segment growth/margin details.
Near-term bias modestly positive, with traders likely focusing on whether travel nurse volume growth sustains and whether language services pricing headwinds persist into 2027.
The article provides concrete earnings and guidance numbers plus segment-level drivers (travel nurse volume +6%, allied +7%, international nurse +23%, locum tenens -8%, language services price -8%). It also flags a 2027 risk from visa appointment backlogs, which can temper the upside.
Market effects
Signals continued normalization of contingent labor premiums and demand recovery in healthcare staffing, but highlights persistent pricing compression in language services.
International nurse growth is supported by visa cutoff movement, but appointment backlogs are flagged as a 2027 growth constraint.
Limited direct global macro linkage; mostly company-specific staffing demand and labor-market dynamics.
Counterpoint
The Q2 margin strength is partly driven by $27M of nonrecurring billing true-ups and reserve adjustments, so underlying profitability may be less durable than headline EBITDA suggests.
Key entities
- companyAMN Healthcare Services, Inc.
Reported Q2 2026 results and issued Q3 revenue and segment guidance, including margin outlook and segment volume/pricing drivers.
- executiveCaroline Grace
CEO who discussed international nurse visa appointment backlog and language services pricing headwinds.
- executiveBrian Scott
CFO who discussed locum tenens volume trends and VMS stabilization expectations.
